Notes
2015 US dollars
Reference
Hospodar AR, et al. Comparing the Cost Effectiveness of Non-vitamin K Antagonist Oral Anticoagulants with Well-Managed Warfarin for Stroke Prevention in Atrial Fibrillation Patients at High Risk of Bleeding. American Journal of Cardiovascular Drugs : 9 May 2018. Available from: URL: http://doi.org/10.1007/s40256-018-0279-y
Rights and permissions
About this article
Cite this article
Warfarin more cost effective than oral anticoagulants. PharmacoEcon Outcomes News 803, 31 (2018). https://doi.org/10.1007/s40274-018-4958-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4958-3